NCT06509594 Scapular Stabilization Exercises Versus Eccentric Muscle Energy Techniques in Patients With Upper Crossed Syndrome
| NCT ID | NCT06509594 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Upper Crossed Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2023-11-23 |
| Primary Completion | 2024-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2023-11-23 with a primary completion date of 2024-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be a Randomized Clinical Trial in which Scapular Stabilization Exercises and Eccentric Muscle Energy technique will be applied on the individuals with upper crossed syndrome and changes will be recorded using different method and tools. Convenient sampling technique will be used to collect the data. The sample size of 34 patients will be recruited. Patients will be randomly allocated into two different groups through sealed envelope method. 17 patients will be allocated in each group. Group A will be treated with Scapular Stabilization Exercises along with hot pack; Group B will be treated with Eccentric Muscle Energy Technique along with hot pack. Craniovertebral Angle (CVA), Numeric Pain Rating Scale (NPRS), and Neck Disability Index (NDI) will be used as Data collecting tools.
Eligibility Criteria
Inclusion Criteria: * • Age: participants having range 18-35 years both male and female are included. * Craniovertebral angle\<52 * NPRS\>3 and NDI\>10 * Patients having neck pain during movements. * Patients having neck pain due to sustained posture and after activity Exclusion Criteria: * Inflammation malignancy, neurological disorder * Metabolic disorders * Neck pain radiating into arms and upper extremity * Neck pain associated with headache and facial pain * Recent surgery * History of recent trauma and fractures of cervical spine * Patients having any other therapeutic intervention or medical treatment.
Contact & Investigator
Dr hajira Anwer, M.S
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06509594 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Upper Crossed Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06509594 currently recruiting?
Yes, NCT06509594 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06509594 trial being conducted?
This trial is being conducted at Sargodha, Pakistan.
Who is sponsoring the NCT06509594 clinical trial?
NCT06509594 is sponsored by Riphah International University. The principal investigator is Dr hajira Anwer, M.S at Riphah International University. The trial plans to enroll 34 participants.